Iwami Daiki, Aramaki Osamu, Shinohara Nobuo, Niimi Masanori, Shirasugi Nozomu
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan; Department of Surgery, Teikyo University, Tokyo, Japan.
Department of Surgery, Teikyo University, Tokyo, Japan; Department of Digestive Surgery, Nihon University, School of Medicine, Tokyo, Japan.
Transpl Immunol. 2018 Oct;50:60-67. doi: 10.1016/j.trim.2018.07.001. Epub 2018 Jul 7.
We previously showed that pretreatment with intratracheal delivery (ITD) of alloantigen induced prolonged cardiac allograft survival and generated regulatory T cells (Tregs) in mice. In this study, we examined the role of splenic dendritic cells (DCs) in the ITD model.
CBA mice were treated with ITD from C57BL/10 splenocytes and 7 days later received transplantation of C57BL/10 hearts. In adoptive transfer studies, splenic DCs from ITD-treated mice were transferred into naïve CBA recipients that received C57BL/10 hearts immediately after the transfer. In addition, to determine the role of splenic DCs isolated from ITD-treated mice, the cells were incubated under stimulation with lipopolysaccharide (LPS).
ITD-treated CBA recipients had markedly prolonged allograft survival (median survival time [MST], 67 days) while naïve recipients rejected allografts acutely (MST, 8 days). In adoptive transfer studies, CBA recipients of the transfer of splenic DCs from ITD-treated mice had prolonged allograft survival (MST, 85 days), while CBA recipients of the transfer of splenic DCs from naïve mice did not have prolonged allograft survival (MST, 8 days). In another transfer study, CBA recipients of the transfer of splenic CD8α DCs from ITD-treated mice had prolonged allograft survival (MST, 79 days), while those receiving splenic CD8α DCs from ITD-treated mice did not have prolonged allograft survival (MST, 8 days). In vitro studies showed that ITD-treated splenic DCs produced more IL-10 and less IL-12 than naïve splenic DCs under stimulation with LPS.
ITD pretreatment induces regulatory DCs, which produce high amounts of IL-10 resulting in the prolongation of graft survival in our model.
我们之前表明,气管内递送(ITD)同种异体抗原预处理可延长小鼠心脏同种异体移植的存活时间,并产生调节性T细胞(Tregs)。在本研究中,我们研究了脾脏树突状细胞(DCs)在ITD模型中的作用。
用来自C57BL/10脾细胞的ITD处理CBA小鼠,7天后接受C57BL/10心脏移植。在过继转移研究中,将经ITD处理小鼠的脾脏DCs转移至未致敏的CBA受体,这些受体在转移后立即接受C57BL/10心脏移植。此外,为了确定从经ITD处理小鼠分离的脾脏DCs的作用,将这些细胞在脂多糖(LPS)刺激下孵育。
经ITD处理的CBA受体的同种异体移植存活时间显著延长(中位存活时间[MST],67天),而未致敏的受体急性排斥同种异体移植(MST,8天)。在过继转移研究中,接受经ITD处理小鼠脾脏DCs转移的CBA受体的同种异体移植存活时间延长(MST,85天),而接受未致敏小鼠脾脏DCs转移的CBA受体的同种异体移植存活时间未延长(MST,8天)。在另一项转移研究中,接受经ITD处理小鼠脾脏CD8α DCs转移的CBA受体的同种异体移植存活时间延长(MST,79天),而接受经ITD处理小鼠脾脏CD8α DCs转移的受体的同种异体移植存活时间未延长(MST,8天)。体外研究表明,在LPS刺激下,经ITD处理的脾脏DCs比未致敏的脾脏DCs产生更多的IL-10和更少的IL-12。
ITD预处理诱导产生调节性DCs,其产生大量IL-10,从而在我们的模型中延长移植物存活时间。